New Technology Could Deliver Drugs to Brain Injuries
Peptide carries molecules and nanoparticles to acutely damaged areas of the brain
Most traumatic brain injuries (TBIs) occur as a result of car crashes, falls and violence. The initial TBI cannot be repaired. However, scientists feel they have found a technology that can limit the damaging effects patients could potentially encounter with a TBI. “We have found a sequence of four amino acids, cysteine, alanine, glutamine and lysine (CAQK), that recognizes injured brain tissue,” said Erkki Ruoslahti, MD, PhD, distinguished in SPB’s NCI-Designated Cancer Center and senior author of the study. “This peptide could be used to deliver treatments that limit the extent of damage.” To read more, click here.
Microsurgery Course Zurich
March 29-April 1, 2017; Zurich, Switzerland
12th World Congress on Brain Injury
March 29-April 1, 2017; New Orleans
2017 National Neuroscience Review
March 31-April 1, 2017; National Harbor, Md.
Brain & Brain PET 2017
April 1-4, 2017; Berlin, Germany
Neurosurgical Society of America Annual Meeting 2017
April 2-5, 2017; Jacksonville, Fla.